首页OPL • ASX
add
Opyl Ltd
市场资讯
财务信息
损益表
收入
净收入
| (AUD) | 2024年12月info | 年同比变化 |
|---|---|---|
收入 | 16.77万 | 37.65% |
经营支出 | 32.34万 | 42.41% |
净收入 | -34.16万 | 46.47% |
净利润率 | -203.67 | 61.11% |
每股收益 | — | — |
息税折旧摊销前利润 | -31.80万 | 25.38% |
有效税率 | — | — |
资产负债表
总资产
负债总额
| (AUD) | 2024年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 32.95万 | -43.64% |
总资产 | 38.48万 | -41.63% |
负债总额 | 69.58万 | -3.76% |
权益总额 | -31.10万 | — |
发行在外的股份 | 1.71亿 | — |
市净率 | ∞ | — |
资产回报率 | -208.46% | — |
资本回报率 | -683.20% | — |
现金流
现金净变动
| (AUD) | 2024年12月info | 年同比变化 |
|---|---|---|
净收入 | -34.16万 | 46.47% |
来自运营的现金 | -31.00万 | -6.88% |
投资现金 | -662.00 | — |
融资现金 | 28.81万 | -19.06% |
现金净变动 | -2.25万 | -134.21% |
自由现金流 | -20.07万 | 18.01% |
简介
Opyl is a Melbourne-based company listed on the Australian Securities Exchange that applies artificial intelligence to improving clinical trial efficiencies. The company has two key platforms: Opin a global clinical trial recruitment platform and service as well as TrialKey a Saas software as a service platform that predicts and designs optimized clinical trial protocols, reducing the risk of failure and improving a return on investment in new and emerging medicines, devices, and diagnostics..
Opyl is a rebrand and strategic realignment from a former company known as ShareRoot, a US-based martech platform that secured rights to user-generated content on social media, predominantly used by big brands that collaborated with influencers.
Before going public in 2016, ShareRoot had previously participated in 500 Startups batch 8 and raised a round of angel investing.
ShareRoot was rebranded to Opyl in 2020 to work on technology to support the health and life sciences sector. Wikipedia
成立时间
2013
网站
员工数量
3
